The buying is certainly forward looking. I think the expectation is for revenue in the second half of this calendar year to increase significantly. Saudi Arabia and Turkey are both robust markets and the adoption in my opinion could ramp up very quickly. To add to this South Korea could grant orphan status to Oncosil very soon of which is super exciting.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-4
Add to My Watchlist
What is My Watchlist?
